ResMed (RMD) | Financial Analysis & Statements

ResMed Inc. | Large-cap | Healthcare

$256.96

0.42%

ResMed vs Intuitive Surgical ResMed vs Becton, Dickinson ResMed vs Alcon ResMed vs West Pharmaceutical ResMed vs Baxter International ResMed vs S&P 500 | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 4.7B

Gross Profit 2.7B 56.67%

Operating Income 1.4B 29.54%

Net Income 1.0B 21.79%

EPS (Diluted) $6.92

Balance Sheet Metrics

Total Assets 6.9B

Total Liabilities 2.0B

Shareholders Equity 4.9B

Debt to Equity 0.41

Cash Flow Metrics

Operating Cash Flow 1.4B

Free Cash Flow 1.3B

Revenue & Profitability Trend

ResMed Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue	4.7B	4.2B	3.6B	3.2B	3.0B
Cost of Goods Sold	2.0B	1.9B	1.6B	1.4B	1.2B
Gross Profit	2.7B	2.4B	2.0B	1.8B	1.7B
Operating Expenses	1.2B	1.2B	991.1M	895.7M	878.6M
Operating Income	1.4B	1.2B	1.0B	912.4M	809.1M
Pre-tax Income	1.3B	1.1B	960.5M	883.7M	733.1M
Income Tax	243.8M	204.1M	181.0M	409.2M	111.4M
Net Income	1.0B	897.6M	779.4M	474.5M	621.7M
EPS (Diluted)	$6.92	$6.09	$5.30	$3.24	$4.27

Income Statement Trend

ResMed Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	2.4B	2.4B	1.9B	1.6B	1.5B
Non-Current Assets	4.5B	4.4B	3.2B	3.2B	3.1B
Total Assets	6.9B	6.8B	5.1B	4.7B	4.6B
Liabilities
Current Liabilities	910.7M	758.5M	689.3M	911.8M	602.8M
Non-Current Liabilities	1.1B	1.9B	1.0B	930.7M	1.5B
Total Liabilities	2.0B	2.6B	1.7B	1.8B	2.1B
Equity
Total Shareholders Equity	4.9B	4.1B	3.4B	2.9B	2.5B

Balance Sheet Composition

ResMed Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income	1.0B	897.6M	779.4M	474.5M	621.7M
Operating Cash Flow	1.4B	799.9M	498.6M	798.2M	821.7M
Investing Activities
Capital Expenditures	-99.5M	-119.7M	-134.8M	-102.7M	-95.3M
Investing Cash Flow	-254.4M	-1.1B	-208.7M	-144.3M	-169.3M
Financing Activities
Dividends Paid	-282.3M	-258.3M	-245.3M	-226.7M	-225.1M
Financing Cash Flow	-1.1B	422.9M	-128.4M	-764.6M	-317.3M
Free Cash Flow	1.3B	559.3M	195.1M	619.9M	696.3M

Cash Flow Trend

ResMed Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 28.60

Forward P/E 24.73

Price to Book 6.73

Price to Sales 7.43

PEG Ratio 24.73

Profitability Ratios

Profit Margin 26.15%

Operating Margin 33.00%

Return on Equity 25.81%

Return on Assets 14.01%

Financial Health

Current Ratio 3.41

Debt to Equity 15.14

Beta 0.77

Per Share Data

EPS (TTM) $8.90

Book Value per Share $37.83

Revenue per Share $34.20

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
rmd	37.3B	28.60	6.73	25.81%	26.15%	15.14
Intuitive Surgical	184.6B	75.42	10.79	15.96%	28.41%	0.00
Becton, Dickinson	48.6B	32.89	1.93	5.89%	7.18%	76.34
Alcon	42.8B	38.45	1.95	5.23%	11.28%	23.63
West Pharmaceutical	16.0B	34.96	5.96	17.42%	16.13%	11.46
Baxter International	15.4B	133.76	2.17	-3.51%	-5.20%	146.14

Financial data is updated regularly. All figures are in the company's reporting currency.